Topical application of a novel anti-interleukin-17A antibody fragment penetrates psoriatic skin: Results of a randomized, double-blind, placebo-controlled phase 1b study - supplementary data
Published: 12 September 2022| Version 1 | DOI: 10.17632/j6ys2x8g4g.1
Contributors:
Rod Sinclair, Sammy Sharifeh, Susan Thackwray, Jason Lickliter, Junlong Wu, Jing Li, Bei Qi, Philip Bland-Ward, Harald ReinhartDescription
Supplementary methods, tables and figures
Files
Categories
Cytokines, General Dermatology, Medical Dermatology, Immunodermatology, Psoriasis